19Indexed trials
mesh condition
Dyskinesias
Intelligence
Dyskinesias intelligence: 19 indexed trials, 1 recruiting studies, 17 sponsors across 18 countries.
1Recruiting
17Sponsors
18Countries
Leading sponsors
Addex Pharma S.A.20 recruiting
National Institute of Neurological Disorders and Stroke (NINDS)20 recruiting
Adamas Pharmaceuticals, Inc.10 recruiting
Appello Pharmaceuticals, Inc.11 recruiting
Assiut University10 recruiting
Daiichi Sankyo10 recruiting
Duke University10 recruiting
EMD Serono10 recruiting
Loma Linda University10 recruiting
NeuroSearch A/S10 recruiting
Oregon Health and Science University10 recruiting
Prilenia10 recruiting
Geographic activity
United States15trials
Germany3trials
Romania2trials
France2trials
Spain2trials
Guatemala1trials
Hungary1trials
Australia1trials
Italy1trials
New Zealand1trials
Puerto Rico1trials
Slovenia1trials
Leading interventions
Dipraglurant2trials
ACP-1031trials
ACR3251trials
ADS-51021trials
AP-4721trials
All investigations; laboratory and radiological, needed for diagnosis1trials
Amantadine1trials
CADD-Legacy® 1400 ambulatory infusion pump1trials
Cannabidiol1trials
Cerebellothalamic optimized deep brain stimulation1trials
Intravenous Levodopa1trials
J-tube1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.